Desk›Healthcare› Sai Life Sciences Ltd
Sai Life Sciences Ltd
BSE 544306 · NSE SAILIFE · ISIN INE570L01029 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,480.55
-0.57%
BSE close, 28 August 2026
₹31,434.04 cr
21.2 cr shares · Mid cap
₹20,231.58 cr
as published
88.7× · —
EPS ₹16.70 · BV —
2,153.23 / 341.48
₹ cr, as filed
26
5 selected · 19%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -1.8% |
|---|---|
| Against 52-week low | +88.3% |
| Day change | -0.57% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹16.70 |
|---|---|
| Price / earnings | 88.66× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | 26.24% |
| Net margin | 13.05% |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 546.73 | 71.34 | 3.36 | 26.24% | 13.05% |
| Mar-26 · Q | 594.34 | 102.53 | 4.85 | 30.99% | 17.25% |
| FY25-26 | 2,153.23 | 341.48 | 16.27 | 29.77% | 15.86% |
Quarter on quarter
- Revenue, quarter on quarter
- -8.0%
- Net profit, quarter on quarter
- -30.4%
- Operating margin, quarter on quarter
- -475 bps
Disclosure profile 26 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| Analyst / Investor Meet | 5 |
| AGM / EGM | 4 |
| ESOP Allotment | 2 |
| Newspaper Publication | 2 |
| Allotment | 1 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| General | 1 |
| Monitoring Agency | 1 |
| Trading Window | 1 |
| Procedural sub-total | 21 |
| Total | 26 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
26 filings · 5 selected · busiest 2026-08-06 and 2026-08-25
Filing rhythm · the twelve most recent
2026-08-252026-10-05
SelectedProcedural
Filings
26 in the window · 6 earlier on record
-
5 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended 30th September 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
1 October 2026 ·
Board Meeting Intimation for Unaudited Financial Results Of Q-2 (FY 2026-27)
Sai Life Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve unaudited financial results ....
Board Meeting / Board Meeting View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window relating to Unaudited Financial Result for the Second Quarter and Half Year Ending on 30th September 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
Allotment of ESOP / ESPS
Allotment of 24,000 Equity Shares having Face Value of Rs. 1/- as per Company's ESOP Plan
Company Update / Allotment of ESOP / ESPS View filing →
-
17 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results and Scrutinizer's Report of 27th Annual General Meeting (AGM) of the Company
AGM/EGM / AGM View filing →
-
17 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 27th Annual General Meeting (AGM) of the Company
AGM/EGM / AGM View filing →
-
4 September 2026 ·
Analyst / Investor Meet - Intimation
Investors Conference - 18th September 2026
Company Update / Analyst / Investor Meet View filing →
-
4 September 2026 ·
Analyst / Investor Meet - Intimation
Investors Conference - 14th September 2026
Company Update / Analyst / Investor Meet View filing →
-
1 September 2026 ·
Allotment of ESOP / ESPS
Allotment of 80,600 Equity shares having Face Value ?1/- each as per Company's ESOP Plans
Company Update / Allotment of ESOP / ESPS View filing →
-
26 August 2026 ·
Newspaper Publication
Newspaper Publication relating to 27th AGM (Post-dispatch Advt.)
Company Update / Newspaper Publication View filing →
-
25 August 2026 ·
Weblink Letter To Shareholders - As Per Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please refer the attachment
Company Update / General View filing →
-
25 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report (BRSR) and ESG Databook of Sai Life Sciences Limited for the FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
25 August 2026 ·
Reg. 34 (1) Annual Report.
Integrated Annual Report of Sai Life Sciences Limited for the FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
25 August 2026 ·
Notice Of 27Th Annual General Meeting (AGM) Of The Company
Notice of 27th Annual General Meeting (AGM) of the Company
AGM/EGM / AGM View filing →
-
24 August 2026 ·
Newspaper Publication
Newspaper Publication relating to 27th AGM (Pre-dispatch Advt.)
Company Update / Newspaper Publication View filing →
-
24 August 2026 ·
Information Relating To 27Th Annual General Meeting (AGM) And Cut-Off Date For E-Voting.
Information relating to 27th Annual General Meeting (AGM) and Cut-off date for e-voting.
AGM/EGM / AGM View filing →
-
12 August 2026 ·
Earnings Call Transcript
Transcript of Earnings Conference Call organised on 07 August 2026
Company Update / Earnings Call Transcript View filing →
-
7 August 2026 ·
Monitoring Agency Report
Monitoring Agency Report for the Quarter ended on 30 June 2026
Company Update / Monitoring Agency Report View filing →
-
7 August 2026 ·
Analyst / Investor Meet - Outcome
Recording of Earnings Call for the Unaudited Financial Results of the Company for the quarter ended on 30 June 2026.
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026 ·
Investor Presentation
Investor Presentation for the quarter ended on 30 June 2026
Company Update / Investor Presentation View filing →
-
6 August 2026 ·
Allotment
Allotment of 18,700 equity shares under Employee Stock Option Plan
Company Update / Allotment of Equity Shares View filing →
-
6 August 2026 ·
Press Release For The Unaudited Financial Results For The Quarter Ended On June 30, 2026
Press Release for the Unaudited financial results for the quarter ended 30 June 2026
Company Update / Press Release / Media Release View filing →
-
6 August 2026 ·
Considered And Approved Unaudited Financial Results For The Quarter Ended On 30 June, 2026.
Unaudited Financial results (Standalone and Consolidate) for the Quarter ended on 30 June 2026
Result / Financial Results View filing →
-
6 August 2026 ·
Board Meeting Outcome for Considered And Approved The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended On 30 June 2026
Board Meeting Outcome for Approval of Unaudited Financial Results (Standalone and Consolidated) For the Quarter Ended On 30 June 2026
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026 ·
Analyst / Investor Meet - Intimation
Analyst/Investor Meet on 13 August 2026 and 14 August 2026 at Singapore
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Analyst / Investor Meet - Intimation
Earnings Conference call Invite to discuss Un-audited Financial Results of the Company for the Quarter ended 30 June 2026.
Company Update / Analyst / Investor Meet View filing →
RSS feed for Sai Life Sciences Ltd · the 50 most recent filings